Imamura N, Kuramoto A, Kawaguchi Y, Tanaka R
Rinsho Ketsueki. 1989 Jan;30(1):11-21.
Pretreatment peripheral and/or bone marrow blasts from 14 patients with acute unclassifiable leukemia (AUL) expressing myeloid related cell-surface antigen (CDII) or megakaryocyte-platelet related cell-surface antigen (OKM6), were isolated for further analysis in this study. Among 11 cases of CD11+AUL, despite a lack of myeloperoxidase (MPO) activity, one patient's blasts possessed Auer rod in a basophilic cytoplasm and another one's blasts expressed MPO maintaining the same surface phenotype after 20 months of his clinical course. The blast from 2 cases possessed both myelomonocytic and monocyte-specific antigens on the cell-surface, whereas the remaining nine cases completely lacked monocyte-specific antigen which is detectable by monoclonal antibodies, Mo2, My4 and Leu M3 (CD14). In addition, we revealed the presence of MPO protein in the cytoplasm of 3 cases of AUL patients by cytoplasmic immunofluorescence test utilizing monoclonal antibody (MA1). Following these results, the former was diagnosed as acute myelomonocytic leukemia (AMMoL) and the latter as acute myelogenous leukemia (AML) by immunophenotypic analysis using flow cytometry (FACS IV) and cytoplasmic immunofluorescence test. We have also described three cases of acute megakaryocytic leukemia which were demonstrated by the presence of megakaryocyte-platelet-related cell-surface antigens detected by utilizing flow cytometry and monoclonal antibodies in addition to both the PPO activity which was shown by ultrastructural cytochemistry, and the emergence of differentiation antigens while culturing these leukemic cells. The blast of 1 case possessed both platelet GPIb and GPIIb/IIIa cell-surface antigens detected by 5F1 (CD36), AN51 (CDw42), and J15, P2 and HPL2 (CDw41), respectively, whereas the remaining two cases almont lacked the GPIb cell-surface antigen. Hence, the former was diagnosed as immature (pro) megakaryocytic leukemia and the latter as acute megakaryoblastic leukemia from the viewpoint of immunophenotypic analysis as will be discussed in this article. These leukemic blasts did not express both T-cell lineage antigens which are detectable by monoclonal antibodies, T6 (CD1), T11 (CD2), T3 (CD3), T4 (CD4), T1 (CD5), Tp40, Leu9 (CD7), T8 (CD8), and B-cell lineage antigens which are detectable by monoclonal antibodies, B4 (CD19), B1 (CD20), B2 (CD21) and J5 (CD10).(ABSTRACT TRUNCATED AT 400 WORDS)
本研究分离了14例表达髓系相关细胞表面抗原(CD11)或巨核细胞 - 血小板相关细胞表面抗原(OKM6)的急性未分类白血病(AUL)患者治疗前的外周血和/或骨髓原始细胞,进行进一步分析。在11例CD11 + AUL病例中,尽管缺乏髓过氧化物酶(MPO)活性,但1例患者的原始细胞在嗜碱性细胞质中有Auer小体,另1例患者的原始细胞在其临床病程20个月后仍表达MPO并维持相同的表面表型。2例原始细胞在细胞表面同时具有髓单核细胞和单核细胞特异性抗原,而其余9例完全缺乏可被单克隆抗体Mo2、My4和Leu M3(CD14)检测到的单核细胞特异性抗原。此外,我们通过使用单克隆抗体(MA1)的细胞质免疫荧光试验,在3例AUL患者的细胞质中发现了MPO蛋白。根据这些结果,通过流式细胞术(FACS IV)和细胞质免疫荧光试验进行免疫表型分析,前者被诊断为急性髓单核细胞白血病(AMMoL),后者被诊断为急性髓系白血病(AML)。我们还描述了3例急性巨核细胞白血病,通过流式细胞术和单克隆抗体检测到巨核细胞 - 血小板相关细胞表面抗原,同时超微结构细胞化学显示有血小板过氧化物酶(PPO)活性,并且在培养这些白血病细胞时出现了分化抗原。1例原始细胞分别被5F1(CD36)、AN51(CDw42)以及J15、P2和HPL2(CDw41)检测到同时具有血小板糖蛋白Ib(GPIb)和糖蛋白IIb/IIIa细胞表面抗原,而其余2例几乎缺乏GPIb细胞表面抗原。因此,从免疫表型分析的角度来看,前者被诊断为未成熟(原)巨核细胞白血病,后者被诊断为急性巨核母细胞白血病,本文将对此进行讨论。这些白血病原始细胞不表达可被单克隆抗体T6(CD1)、T11(CD2)、T3(CD3)、T4(CD4)、T1(CD5)、Tp40、Leu9(CD7)、T8(CD8)检测到的T细胞系抗原,也不表达可被单克隆抗体B4(CD19)、B1(CD20)、B2(CD21)和J5(CD10)检测到的B细胞系抗原。(摘要截短于400字)